Literature DB >> 26895430

Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis.

Inna Tabansky1, Mark D Messina2,3, Catherine Bangeranye3, Jeffrey Goldstein2,3, Karen M Blitz-Shabbir2, Suly Machado2,3, Venkatesh Jeganathan4, Paul Wright2, Souhel Najjar2, Yonghao Cao4, Warren Sands5,6, Derin B Keskin7, Joel N H Stern8,9,10,11.   

Abstract

Entities:  

Year:  2016        PMID： 26895430     DOI： 10.1007/s12026-016-8791-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  1 in total

1.  DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.

Authors:  Jeffrey D Price; Chie Hotta-Iwamura; Yongge Zhao; Nicole M Beauchamp; Kristin V Tarbell
Journal:  Diabetes       Date:  2015-06-12       Impact factor: 9.461
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.